Last reviewed · How we verify

NCT04457466

Assessment of the Effects of Extensive Somatosensory Training on Pain Processing

Terminated Last updated 3 March 2022
What this trial tests

trial testing Nerve Growth Factor in Musculoskeletal Pain in 100 participants. Terminated before completion.

Timeline
1 October 2017
Primary endpoint
1 October 2018
1 July 2020

Quick facts

Lead sponsorAalborg University
StatusTerminated
Study typeOBSERVATIONAL
Enrollment100
Start date1 October 2017
Primary completion1 October 2018
Estimated completion1 July 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Musculoskeletal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Persistent pain may lead to several alterations in the brain activity and sensory perception (i.e. pain). Around 80% of professional musicians experience prolonged episodes of musculoskeletal pain throughout their careers, a percentage that is four times higher than in the general population. With this background, the intended experiment aims at understanding the role of several biological factors associated to sensorimotor training that can lead to alteration of the brain activity and, consequently, pain processing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Pain

Currently open trials in the same condition.

Other Aalborg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04457466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing